8-KEarnings & ResultsExhibits & Filings

ALNYLAM PHARMACEUTICALS, INC. 8-K Report, Financial Results (Aug 6, 2008)

Filed August 6, 2008For Securities:ALNY

Summary

Alnylam Pharmaceuticals, Inc. filed an 8-K on August 6, 2008, to announce its financial results for the quarter ended June 30, 2008. The report primarily directs investors to a press release (Exhibit 99.1) containing the detailed financial and operational updates for the period. This filing is crucial for understanding the company's financial performance and strategic developments during the second quarter of 2008. Investors should review the furnished press release for specific details on revenue, expenses, net income (or loss), cash flow, and any significant business updates or pipeline advancements. As this 8-K itself is a notification of the release of financial results rather than the results themselves, the press release will be the primary source of actionable information regarding Alnylam's financial condition and operational highlights.

Key Highlights

  • 1Alnylam Pharmaceuticals reported its financial results for the quarter ended June 30, 2008.
  • 2The company filed a Form 8-K on August 6, 2008, to announce these results.
  • 3The detailed financial information is provided in a press release furnished as Exhibit 99.1.
  • 4Investors are directed to the press release for specific financial data and operational updates.
  • 5The filing confirms that the press release contains the company's results of operations and financial condition for the specified period.
  • 6This report serves as official notification of the release of Alnylam's Q2 2008 financial performance.

Frequently Asked Questions

The detailed financial results are contained within the press release dated August 6, 2008, which is furnished as Exhibit 99.1 to this Form 8-K filing. You should refer to this press release for specific financial performance data.

No, this Form 8-K primarily serves as an announcement that Alnylam Pharmaceuticals has released its financial results. The actual detailed financial information, including statements and operational highlights, is provided in the accompanying press release (Exhibit 99.1).

When information is 'furnished' under Item 2.02 of an 8-K, it is not subject to the same liability under Section 18 of the Securities Exchange Act of 1934 as if it were 'filed'. It also does not automatically get incorporated into other SEC filings. However, it is still publicly accessible information that investors should consider.